Agresywny rak endometrium. Czy pomoże terapia skojarzona? Nowe badania
OA: closed
CC0
AI-generated summary
Researchers from Yale Cancer Center found that combining trastuzumab with chemotherapy significantly improves survival in women with rare, aggressive endometrial cancer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Naukowcy z Yale Cancer Center (YCC) odkryli, ze polączenie celowanego trastuzumabu z chemioterapią znacznie poprawia przezywalnośc kobiet z rzadką, agresywną postacią raka endometrium. Wyniki te mogą pomoc w zmianie standardu opieki nad chorobą na calym świecie. Odkrycia zostaly opublikowane w czasopiśmie Clinical Cancer Research.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK